MHRA launches a new strategy aims to transform the way we provide information on the risks and safety of medicines and medical devices.
The Medicines and Healthcare products Regulatory Agency (MHRA) launched a new three-year Strategy for Improving Safety Communications On World Patient Safety Day, which aims to transform the way we provide information about the risks and safety of medicines, medical devices and healthcare products in the UK to support effective implementation of new safety measures.
Effective communication is essential so that patients are informed of and understand the benefits and risks of medicines and devices they are using, to assist healthcare professionals in best protecting their patients, and to maintain confidence in medical products, the broader health system, and the MHRA.
Healthcare professionals need the latest safety information to advise and support their patients, and we have listened to their feedback in bringing improvements to our communications and systems. Our strategy is underpinned by the findings of our recent consultation with healthcare professionals and healthcare organisations.
The three-year strategy will deliver to patients and healthcare professionals more coordinated, targeted, and impactful safety communications, when they need it, using the best possible communication channels. The new strategy aims to build on the MHRA’s transformed approach to safety following the 2020 Independent Medicines and Medical Devices Safety Review. This called for strengthening the MHRA’s processes for monitoring the safety of medicines and medical devices and better working with other bodies to support changes being embedded without delay in clinical practice.
